KemPharm News

KemPharm Analyst Ratings

Benzinga Analyst RatingsNov 17, 2022 06:22 ET

Cantor Fitzgerald Initiates Coverage On KemPharm With Overweight Rating, Announces Price Target of $20

Benzinga Real-time NewsNov 17, 2022 06:22 ET

H.C. Wainwright Reaffirms Their Buy Rating on KemPharm (KMPH)

TipRanksNov 14, 2022 06:20 ET

KemPharm Analyst Ratings

Benzinga Analyst RatingsSep 15, 2022 06:43 ET

Canaccord Genuity Initiates Coverage On KemPharm With Buy Rating, Announces Price Target of $20

Benzinga Real-time NewsSep 15, 2022 06:41 ET

KemPharm Price Target Cut to $10.00/Share From $11.00 by HC Wainwright & Co.

Dow JonesAug 17, 2022 06:49 ET

KemPharm Is Maintained at Buy by HC Wainwright & Co.

Dow JonesAug 17, 2022 06:49 ET

KemPharm Analyst Ratings

Benzinga Analyst RatingsAug 17, 2022 06:41 ET

HC Wainwright & Co. Maintains Buy on KemPharm, Lowers Price Target to $10

Benzinga Real-time NewsAug 17, 2022 06:40 ET

KemPharm (KMPH) Gets a Buy From H.C. Wainwright

TipRanksAug 17, 2022 06:30 ET